Overview
Germany flavors and fragrances supplier's Q1 2026 organic sales declined 0.4% yr/yr
Company saw solid performance in Food & Beverage, Pet Food, and Fragrance divisions
Full-year 2026 outlook for organic sales growth of 2% to 4% reaffirmed
Outlook
Symrise reaffirms 2026 organic sales growth outlook of 2.0% to 4.0%
Company expects 2026 adjusted EBITDA margin between 21.5% and 22.5%
Symrise targets adjusted Business Free Cash Flow margin above 14.0% for 2026
Result Drivers
SEGMENT PERFORMANCE - Food & Beverage, Pet Food, and Fragrance divisions saw solid or positive organic sales growth, while Care & Wellness and Aroma Molecules declined, mainly due to strong prior-year comparables and price normalization
TRANSFORMATION PROGRAM - Structural cost savings and efficiency gains from the ONE SYM Transformation program supported performance and are intended to unlock organic growth opportunities
Company press release: ID:nEQ5GPKBba
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
EUR 1.25 bln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 17 "strong buy" or "buy", 6 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Symrise AG is €93.50, about 27.3% above its April 28 closing price of €73.44
The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 17 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)